Search PubMed⌕ Search

Biomedical subjects

Y Veillette

Publications and source records attributed to Y Veillette.

8 recordsLinked to original sources
PubMed1996

[Evaluation of the activity of a postoperative analgesia department in a Canadian hospital].

OBJECTIVE: To describe the setting up and the activity of an acute pain service (APS). STUDY DESIGN: Retrospective descriptive study including two surveys among the nursing staff, the first one eight months after the setting up of the APS and the second one ten months later. RESULTS: In the first 19 months, 3,404 patients were treated in the APS: 1,456 with patient-controlled analgesia (PCA), 1,299 with epidural analgesia, 589 with spinal opioids and 60 with continuous nerve blocks. The resulting overall incidence of respiratory depression was 0.7%. It ranged from 0% with continuous nerve block to 1.2% with PCA. It was at 0.3% with epidural analgesia and 0.5% with spinal opioids. Both surveys confirmed that nurses had a positive attitude toward the APS, mainly because they believed it offered patients significant advantages. Many of them thought that epidural analgesia and PCA were likely to impede patient's ambulation and most of them agreed that these techniques increased their work load. CONCLUSION: Although the incidence of respiratory depression was low among the APS patients, it can probably still be decreased by a more refined patient selection. Setting up an APS is viewed positively by the nursing staff in spite of some perceived disadvantages.

Analgesia↗
PubMed1996

Clonidine and or adrenaline decrease lignocaine plasma peak concentration after epidural injection.

Clonidine is an alpha 2-adrenoceptor agonist increasingly used in combination with lignocaine for spinal or epidural anaesthesia because of a prolonged analgesic effect. Life adrenaline, it may decrease lignocaine peak concentration (Cmax), thus leading to decreased toxicity. However, the effects of clonidine on resorption of lignocaine into the systemic circulation from the epidural space remain to be established. We studied the pharmacokinetics of lignocaine after epidural injection of lignocaine with or without clonidine, adrenaline and both drugs. Total body clearance and apparent volume of distribution were similar in the four groups, but the maximum observed concentration (Cmax) was markedly increased in the plain solution group as compared with the other groups; (plain lignocaine: 7.15 +/- 2.04 micrograms ml-1, lignocaine + adrenaline: 3.11 +/- 136 micrograms ml-1, lignocaine + clonidine: 4.48 +/- 1.26 micrograms ml-1, lignocaine + adrenaline + clonidine: 4.06 +/- 1.42 micrograms ml-1 [mean +/- s.d.]). Our results show that, clonidine decreases lignocaine Cmax to the same extent as adrenaline.

Adolescent↗
PubMed1991

Ventilatory effects of premedication with clonidine.

Clonidine has been proposed as a premedication before surgery because of its beneficial effects on hemodynamics, especially in patients with a high cardiovascular risk. However, reports on the effects of clonidine on ventilation are conflicting. Accordingly, eight fasting ASA physical status I volunteers received in a double-blind randomized order 300 micrograms of oral clonidine, the effects of which were compared with placebo given in a crossover design. Hypotension, bradycardia, and sedation were significantly more profound and of longer duration after clonidine. Clonidine did not decrease minute ventilation more than the placebo, and separate analysis of tidal volume and respiratory rate changes also showed the absence of a significant difference between the two groups. However, clonidine produced episodes of obstructive pattern associated with moderate decreases in oxygen saturation, which were not observed with placebo. We conclude that the potential detrimental effects of these obstructive airway patterns of clonidine should be taken into account when prescribing this drug for premedication.

Administration, Oral↗
PubMed1990

[Continuous block of the femoral nerve after surgery of the knee: pharmacokinetics of bupivacaine].

Ten ASA Class 1 and 2 patients, aged from 16 to 56 years (mean +/- SD: 37 +/- 17 years), scheduled for knee surgery were studied. At the end of the surgical procedure under general anesthesia, an epidural catheter was inserted in the femoral space. After X-ray opacification, a bolus of 2.5 mg.kg-1 of 0.5% bupivacaine with epinephrine was injected. A maintenance infusion was performed during 48 hours with 0.25 mg.kg-1.h-1 of 0.125% bupivacaine without epinephrine. Pain score recorded with an visual analogue scale was 5.0 +/- 1.9 before femoral block. Pain score decreased significantly from 6 to 48 hours. Plasma bupivacaine levels at 24, 36 and 48 hours were significantly higher than the levels obtained at 30 min, 1, 6 and 12 hours. Mean plasma bupivacaine level at steady state was 1.78 +/- 0.59 micrograms.ml-1. Clearance of bupivacaine was 2.59 +/- 0.91 ml.min-1.kg-1. No neurologic complications have been recorded.

Adolescent↗
PubMedDate not supplied

Back pain following epidural anesthesia with 2-chloroprocaine (EDTA-free) or lidocaine.

BACKGROUND AND OBJECTIVES: Severe lumbar pain following epidural injection of 2-chloroprocaine is usually associated with the Nesacaine-MPF solution available in the United States. The purpose of this study was to determine if the solution distributed in Canada (Nesacaine-CE), which contains calcium disodium edetate (0.1 mg/mL) and sodium bisulfite (0.7 mg/mL) but no disodium ethylenediaminetetraacetic acid, is associated with back pain or spasm when compared with epidural lidocaine. METHODS: With use of a prospective, double-blind, randomized design, 30 patients scheduled to undergo outpatient knee arthroscopy under epidural anesthesia were divided into two groups to received 30 mL of either Nesacaine-CE 3% (group A) or lidocaine 1.33% (group B). Postoperative pain in the lumbar area was assessed twice by a 10-cm visual analog scale (VAS) before patients left the hospital and 24 hours later by phone. The lumbar area was palpated to search for muscle spasm before discharge from hospital. RESULTS: More patients receiving Nesacaine-CE than receiving lidocaine suffered from back pain in the recovery room (four vs none P = .03) and before leaving the hospital (nine vs one P = .001). Higher VAS scores (mean +/- SE) were obtained after Nesacaine CE then after lidocaine in the recovery room (0.5 +/- 0.24 vs 0.0 +/- 0.0, p = .049) and before leaving the hospital (1.8 +/- 0.5 vs 0.1 +/- 0.1, P = .001). No difference existed 24 hours later between the two groups with regard to the prevalence of back pain or VAS scores. No muscle spasm was detected. CONCLUSION: No cases of severe backache were observed. However, epidural Nesacaine-CE 3% was associated with mild back pain, generally confined to the area of needle insertion, when compared with lidocaine 1.33%.

Adult↗